Claire Friedman

16PUBLICATIONS
132CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Reproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 01, 2025
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA.

Marc J Williams, Ignacio Vázquez-García, Grittney Tam

|Jul 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer.

Andrew McPherson, Ignacio Vázquez-García, Matthew A Myers

|Jun 13, 2025
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial.

Funda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney

|Jan 06, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.

Juanita Lopez, Thomas Powles, Fadi Braiteh

|Sep 10, 2024
The Intrauterine Device: How to Deploy This Strategy in the Molecular World?

Paul Johannet, Claire F Friedman

|Apr 23, 2024
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.

Claire F Friedman, Beryl L Manning-Geist, Qin Zhou

Pageof 3

Frequent Collaborators

6 joint publications

Dmitriy Zamarin

6 joint publications

Britta Weigelt

4 joint publications

Yulia Lakhman

3 joint publications

Alexia Iasonos